An Observational Study of the Risk of Acute Pancreatitis in Subjects Exposed to Albiglutide, Other GLP-1 Agonists or DPP-4 Inhibitors Compared to Other Antidiabetic Agents (201804)

First published 27/01/2016

Last updated 18/04/2024

EU PAS number:

EUPAS11845

Study

Finalised

Documents

Study protocol

Initial protocol

gsk-201804-protocol-redact

English (6.79 MB - PDF)View document

Study results

gsk-201804-clinical-study-report-redact

English (726.28 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs